Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
A study published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University shows how common ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...
New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...
The event, held in the emblematic Casa de Convalescència, was supported by the BBVA Foundation and welcomed 150 international ...
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...